MPXOF (MPX International) ROE % Adjusted to Book Value: -423.24% (As of Mar. 2022)


What is MPX International ROE % Adjusted to Book Value?

MPX International MPXOF -99.00% ROE % Adjusted to Book Value is -423.24% as of Mar. 2022.

MPX International's ROE % for the quarter that ended in Mar. 2022 was -317.43%. MPX International's PB Ratio for the quarter that ended in Mar. 2022 was 0.75. MPX International's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2022 was -423.24%.

MPX International ROE % Adjusted to Book Value Related Terms

MPX International ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for MPX International's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MPX International ROE % Adjusted to Book Value Chart

MPX International Annual Data
Trend Sep18 Sep19 Sep20 Sep21
ROE % Adjusted to Book Value
0.00 -21.71 -203.67 -186.91

MPX International Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -155.67 -52.04 -412.89 -314.00 -423.24

MPXOF vs ZTS, CTLT, VTRS: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MPX International ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where MPX International's ROE % Adjusted to Book Value falls into.


MPX International ROE % Adjusted to Book Value Calculation

MPX International's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2021 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-106.54% / 0.57
=-186.91%

MPX International's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-317.43% / 0.75
=-423.24%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -423.24% mean?
MPX International (MPXOF) has a ROE % Adjusted to Book Value of -423.24% as of Mar. 2022. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MPX International and its competitors.
Is MPX International's ROE % Adjusted to Book Value too high?
MPX International's current ROE % Adjusted to Book Value is -423.24%.
How does MPX International's ROE % Adjusted to Book Value compare to ZTS and CTLT?
MPX International's ROE % Adjusted to Book Value of -423.24% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MPX International and its competitors. MPX International's current ROE % Adjusted to Book Value is -423.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPX International stock overvalued right now?
MPX International (MPXOF) has a current ROE % Adjusted to Book Value of -423.24%. The current ROE % Adjusted to Book Value is -423.24%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For MPX International (MPXOF), the current ROE % Adjusted to Book Value is -423.24% as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MPX International Business Description

Address 5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.